All Posts in Category:

Trusted Health Resources for COVID-19
One part of managing mental (and physical) health during the COVID-19 pandemic is choosing trusted news sources when you're looking for information. The National Alliance on Mental Illness (NAMI) has the following guidelines for consuming COVID-19-related
Untreated Depression & Anxiety Linked to Future Memory Loss
Recent University of Sussex findings from the National Child Development Study (NCDS) in Britain have pointed to episodes of depression being associated with loss of memory function later in life. The study, which began in 1958 and involves 18,000 participants from birth onto adulthood, found that more than one period of depression or anxiety in an individual’s 20s-40s predicted cognitive impairment in their 50s.
TMS Therapy Helping Teens With Treatment Resistant Depression
Teenage rates of depression are appalling; according to the National Comorbidity Survey-Adolescent Supplement (NCS-A) about 11% of adolescents have a depressive disorder by age 18. If we take the 2008 census, roughly over 2 million teens are currently experiencing depression symptoms.
TMS Therapy Shows Long-Term Benefits In Difficult-To-Treat Patients With Depression
The first successful transcranial magnetic stimulation was performed in 1985 and it has opened doors for a widespread variety of therapy interventions for a multitude of diseases, with depression being the most studied area. Although transcranial magnetic stimulation has been around for over 20 years, it’s only in recent years that it has become a widely acceptable and valuable treatment for major depression. This is due to investigators worldwide completing more than 30 randomized, controlled clinical trials proving time and time again that TMS Therapy is an effective treatment for depression.[1]
Transcranial Magnetic Stimulation, a Breakthrough Treatment for Migraine Relief?
Transcranial Magnetic Stimulation (TMS) therapy has been widely used in treating the symptoms of depression. Recent studies, such as those done at the American Academy of Neurology 1and the University of Duisburg-Essen2 in Germany, are now showing the extensive potential TMS therapy has in the treatment of migraines. What’s more, studies are indicating the potential TMS therapy has in opening doors for safer and more effective treatment of many other brain-related illnesses including tinnitus, auditory hallucinations, anxiety disorders, and schizophrenia.
Depression Can Drive Up Cancer, Injury Risk
Depression already causes a variety of unwelcomed symptoms such as fatigue and insomnia, which largely interrupt daily activities. Without proper treatment, this illness can ruin careers, families and relationships. Patients suffering from depression endure a large number of obstacles – physical, emotional and even economical – and recent articles are now showing that it can also put you at a higher risk for other health problems you would otherwise not experience.
TMS Therapy to Treat Fibromyalgia
Fibromalgia is a common syndrome in which a person has long-term, body-wide pain and tenderness in the joints, muscles, tendons, and other soft tissues. It has also been linked to fatigue, sleep problems, headaches, depression, and anxiety[1]. Pain can drastically alter and reduce a person’s quality of life and current treatment options – including antidepressants[2] – are known for causing unwanted side effects. While TMS Therapy has so far only been FDA cleared for the treatment of Major Depression, there have been several studies suggesting that TMS can also be extremely beneficial for other disorders and diseases, such as Fibromyalgia. A study on the Efficacy of Transcranial Direct Current Stimulation and Repetitive Transcranial Magnetic Stimulation for Treating Fibromyalgia Syndrome has concluded that TMS showed analogous pain reductions as well as considerably fewer side effects compared to FDA approved FMS pharmaceuticals[3].
Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life
- Percentage of Patients Reporting a Return to Normal Activities More Than Tripled Following Treatment with NeuroStar TMS Therapy® - PHILADELPHIA, May 8, 2012 – New data released today at the annual meeting of the AmericanPsychiatric Association show that patients with unipolar, non-psychotic Major Depressive Disorder (MDD) receiving transcranial magnetic stimulation (TMS) with NeuroStar TMS Therapy® achieved significant improvements in both depression symptoms and in quality of life measurements. Overall, 58 percent of patients achieved a positive response to NeuroStar TMS therapy, with 37 percent of patients achieving remission from their depression.After an average of five weeks of NeuroStar treatment, the percentage of patients reporting extreme problems with anxiety and depression decreased by 42.2 percent, demonstrating a reduction in depression symptomatology. For overall treatment effect, the percentage of patients reporting no problems in performing usual activities improved
TMS NeuroHealth Centers: First Non-Drug Treatment for Depression Center in Tyson’s Corner
It is now official! Our first Greenbrook TMS NeuroHealth Centers location is open for business. The first of a national network of centers offering Transcranial Magnetic Stimulation Therapy, Tyson’s Corner (McLean, Virginia) opened its doors in November, 2011. TMS Therapy is an FDA-cleared, non-invasive medical treatment for patients with depression without any of the side effects typically experienced with antidepressant medication, such as weight gain, sexual problems or fatigue. It uses highly focused magnetic pulses to gently stimulate the area of the brain that controls mood. This specific area has been identified as under active in people who suffer from depression. Stimulation leads to the release of chemical neurotransmitters, relieving the symptoms of depression.